Abstract: An information handling system includes a flash device interface and a flash device. The flash device includes a flash controller and a flash array. The flash device interface programs a command register of the flash controller with a first value, and reads a status register of the flash controller. The flash device interface further determines that a usage of the flash device is in accordance with one of a first usage model and a second usage model based upon a value in the first status register. When the usage is in accordance with the first usage mode, the flash device interface retains the first value in the command register. When the usage is in accordance with the second usage model, the flash device interface reprograms the command register with a second value. The command register controls a read threshold count value for reading data from the flash array.

Abstract: A circuit board, according to an embodiment, comprises: a first insulating layer; a second insulating layer disposed on one surface of the first insulating layer; and a third insulating layer disposed on the other surface of the first insulating layer. A circuit pattern is disposed on at least one insulating layer from among the first to third insulating layers, at least one insulating layer from among the first to third insulating layers comprises glass fiber, at least one insulating layer from among the first to third insulating layers does not comprise glass fiber, and the thicknesses of the first to third insulating layers are different from each other.

Abstract: Disclosed is a technique for switching from a master node to a secondary node in a communication system. A method of a first communication node may comprise: adding the first communication node as a primary secondary cell (PSCell) to a second communication node through dual connectivity (DC); generating a first user plane path for smart dynamic switching (SDS) and a first instance for supporting the first user plane path according to a request from the second communication node; transmitting information on the first user plane path and the first instance to a terminal; receiving user data based on the first user plane path from the terminal as the first instance; and transmitting the user data to a core network using the first user plane path.

Abstract: A lithium secondary battery based on one embodiment of the disclosed technology comprises an exterior member; and electrode cells disposed within the exterior member and each comprising a cathode, an anode, and a separator disposed between the cathode and the anode. Cathode tabs are disposed on a first side of the cathode. Anode tabs are disposed on a second side of the anode that is different from the first side. The cathode tabs and the anode tabs are formed asymmetrically on different sides.

Abstract: A display device is provided including a substrate. A second semiconductor layer is disposed on the substrate. The second semiconductor layer includes Si. A second gate lower electrode overlaps a channel region of the second semiconductor layer. A second gate insulating layer is disposed on the second gate lower electrode. A second gate upper electrode and a light blocking layer are disposed on the second gate insulating layer. A first auxiliary layer is disposed on the second gate upper electrode and the light blocking layer. A first semiconductor layer overlaps the light blocking layer. The first semiconductor layer includes an oxide semiconductor. A first gate electrode overlaps a channel region of the first semiconductor layer. The first auxiliary layer includes an insulating layer including at least one compound selected from SiNx, SiOx, and SiON, and at least one material selected from F, Cl, and C.

Abstract: A display device includes: a pixel defining layer defining openings arranged in first and second directions, the openings forming emission areas in which light emitting elements are disposed to emit light of different colors; a light blocking layer disposed on the pixel defining layer, and defining holes, each overlapping the opening and having a larger diameter than the opening; and color filters disposed on the light blocking layer to overlap the holes and overlap the emission areas. The opening has an opening interval, which is defined as a difference in diameter between the overlapping hole and the opening, in the openings, among homogeneous openings in which the light emitting elements for emitting light of the same color are disposed, the homogeneous openings adjacent in the first or second direction have different opening intervals, and among the homogeneous openings, openings having different opening intervals are at least three types.

Abstract: Aspects of this disclosure improve data availability by decreasing access times to obtain data from the storage device while still providing high memory density. A method may include identifying, by a controller of a non-volatile solid-state storage device, first data that matches a criteria based on access information regarding data stored in a solid state drive as targeted data; writing, by the controller of the non-volatile solid-state storage device, the targeted data from a first portion of the non-volatile solid-state storage device configured as a first type to a second portion of the non-volatile solid-state storage device configured as a second type; and tagging, by the controller of the non-volatile solid-state storage device, the data with a tag based on the access information. Other aspects are also disclosed.

Abstract: Disclosed are a carboxamide derivative and a pharmaceutical composition comprising same as an active ingredient for use in preventing or treating mental illness. The derivative is superbly effective in a triple reuptake inhibitor of serotonin, norepinephrine, and dopamine, and thus can be effectively used in treating mental illness.

Abstract: Disclosed is a mono-azo dichroic dye compound represented by the following Chemical Formula 1, a composition for polarizing plate, a polarizing plate, and an optical device. In Chemical Formula 1, Z represents any one selected from the group consisting of CN, COOR11, indanone and 1,3-dioxoindane, wherein R11 is any one selected from the group consisting of alkyl groups, aryl groups, and substituted or non-substituted heteroaryl groups. The mono-azo dichroic dye compound shows excellent dichroic properties, and has excellent heat resistance and photo-resistance, and thus may be used advantageously for a dye-based polarizing plate.

Abstract: Disclosed is a mono-azo dichroic dye compound represented by the following Chemical Formula 1, a composition for polarizing plate, a polarizing plate, and an optical device. In Chemical Formula 1, R3 represents a substituted or non-substituted heterocyclic group having 1-20 carbon atoms. The mono-azo dichroic dye compound shows excellent dichroic properties, and has excellent heat resistance and photo-resistance, and thus may be used advantageously for a dye-based polarizing plate.

Abstract: The present invention relates to a 3-((8-((1H-pyrazol-4-yl)amino)imidazo[1,2-a]pyridin-3-yl)ethynyl)-N-phenylbenzamide derivative, a method for preparing the same, and a pharmaceutical composition comprising the same as an active ingredient for preventing or treating cancer. The derivative can significantly inhibit the proliferation of cancer cells by inhibiting kinases, particularly Bcr-Abl kinase or Bcr-Abl (T315I) kinase. Therefore, the derivative can be effectively used as a pharmaceutical composition for the prevention or treatment of cancer.

Abstract: Provided are an antibody that binds specifically to N-terminal pro-B-type natriuretic peptide (NT-proBNP) and use thereof. An antibody or antigen-binding fragment thereof, which binds specifically to an epitope of NT-proBNP including the amino acid sequence of HXLGXXX (SEQ ID NO: 2), may detect NT-proBNP, which is a heart disease biomarker, and heart disease can also be effectively diagnosed by using the same.

Abstract: The present invention relates to a 5-membered heteroaryl derivative containing an N, and a pharmaceutical composition for use in preventing or treating mental disorders, containing same as an active ingredient, wherein the derivative is excellent in the triple reuptake inhibitory effect of serotonin, norepinephrine, and dopamine, and thus can be useful in the treatment of mental disorders.

Abstract: Disclosed are a sulfonamide derivative and a pharmaceutical composition comprising same as an active ingredient for use in preventing or treating mental illness. The derivative is superbly effective in a triple reuptake inhibitor of serotonin, norepinephrine, and dopamine, and thus can be effectively used in treating mental illness.

Abstract: In a method of forming patterns, first and second upper reverse patterns are formed on a lower reverse layer. A buffer layer is formed to fill first opening portions provided by the first upper reverse pattern. A shield pattern is formed to cover a second region of the buffer layer. An etching process is performed using the shield pattern and the first upper reverse pattern as an etching mask to form first lower reverse patterns providing second openings overlapping first openings, a buffer layer pattern and a second lower reverse pattern overlapping the shield pattern. A hard mask layer is formed and etched to separate hard mask layer first patterns filling the first and second openings. An etching process is performed using the hard mask layer first patterns and the second upper reverse patterns as etching masks to form third lower reverse patterns overlapping the second upper reverse pattern.

Abstract: The present invention relates to a method for preparing a biomaterial having selectively functionalized tyrosine, a biomaterial having selectively functionalized tyrosine, and a pharmaceutical composition containing the same as an active ingredient. The method for preparing a biomaterial to which a compound represented by formula 2 is coupled, of the present invention, allows the compound represented by formula 2 to be selectively coupled, in a high yield in a biomaterial, to tyrosine, which is present on the surface of an aqueous solution such that the coupling thereof to amino acids other than tyrosine does not occur and, when only one tyrosine is present, heterogeneous mixtures are not present and the inherent activity of the biomaterial is maintained, and thus the compound can be effectively used as a pharmaceutical composition containing a biomaterial drug as an active ingredient.

Abstract: Provided is a novel compound and a use thereof. A novel compound according to the presently claimed subject matter induces the activation of MKP-1 protein to block the cellular signaling pathway proceeding in the order of p38/CK2?/NF-?B, thereby very effectively inhibiting an inflammatory response occurring in a respiratory disease. Therefore, a respiratory disease can be prevented, alleviated, or treated by orally administering the novel compound according to the presently claimed subject matter.

Abstract: Provided is a monitoring system including an image obtaining apparatus and an image processing apparatus. The image obtaining apparatus includes: a camera; a beacon sensor; a processor configured to match beacon information obtained by detecting, by the beacon sensor, a beacon attached to an object existing in a monitoring region, to an image of the monitoring region captured by the camera; and a memory storing the image matched with the beacon information.

Abstract: An electrode structure for a secondary battery includes a current collector, a first active material layer formed on at least one surface of the current collector, a second active material layer on the first active material layer, and a conductive intermediate layer interposed between the first active material layer and the second active material layer. The conductive intermediate layer has a resistance lower than each resistance of the first active material layer and the second active material layer. A lithium secondary battery including the electrode structure is provided.

Abstract: A driving system includes a central controller, a plurality of driving paths forming a least crossing position, and a plurality of autonomous driving devices configured to drive along at least one of the driving paths through the crossing position. The central controller is configured to determine a plurality of target driving devices from among the autonomous driving devices that are within a certain range of the crossing position, designate one of the target driving devices as a master driving device and the other of the target driving device as slave driving devices. The master driving device controls passage of the slave driving devices through the crossing position.